Authors: ALEXANDER M ALLISON D AULD E BARBER C BEECHER C BEIM A BIER D BROCK C BROIHIER C BYAL N CHAPPELL J CIAMPA L CLARK A CLARK K COBE P EDELSON A ELAM K ELLIS M GRAVANI R GREENWELL M GREER K GUNBY P HAHN B HAIKEN M HAYES JL HEAD A HILL J HORTON S HOWKINS MA HOWZE E INGENTHRON G JACOBS C JIBRIN J KATALINICH P KNUTH K LANE S LATONA V LEVY S LINDNER L MARGOLIS D MCDONOUGH B MELTON J MELTON R MONSEN ER MORGAN A MUDD M PAULSON T PIERRE C PRATT S PRICE F PROULX L RICHTER E ROWE S SHEPERS A SOMER E STARNES S STRAUS K THOMPSON B WELCH C WINSTON M YAP L

Citation: M. Alexander et al., IMPROVING PUBLIC UNDERSTANDING - GUIDELINES FOR COMMUNICATING EMERGING SCIENCE ON NUTRITION, FOOD SAFETY AND HEALTH, Journal of the National Cancer Institute, 90(3), 1998, pp. 194-199

Authors: STEPHENSON J BAKER SD AYLESWORTH C SIU L SIMMONS C SHARMA S SMITH L PROULX L MARSOLAIS C HUNT W VONHOFF D ROWINSKY E

Citation: J. Stephenson et al., A PHASE-I SAFETY AND PHARMACOKINETIC (PK) STUDY OF BCH-4556, A NOVEL L-NUCLEOSIDE ANTIMETABOLITE, ON A DAILY X 5 DAY EVERY 21-DAY SCHEDULE IN PATIENTS WITH SOLID NEOPLASMS, Annals of oncology, 9, 1998, pp. 596-596

Authors: BELANGER K MOORE M DIONNE J MCLEAN M PROULX L HUNT W MARSOLAIS C BAKER S WAINMAN N SEYMOUR L

Citation: K. Belanger et al., A PHASE-I STUDY OF THE NOVEL L-NUCLEOSIDE ANALOG BCH-4556 GIVEN EVERY21 DAYS, Annals of oncology, 9, 1998, pp. 601-601

Authors: MCMACKIN D DUBEAU F JONESGOTMAN M GOTMAN J LUKBAN A LISBONA R DEAN G PROULX L TAMPIERI D

Citation: D. Mcmackin et al., FUNCTIONAL INACTIVATION OF HIPPOCAMPUS DURING THE INTRACAROTID SODIUMAMOBARBITAL PROCEDURE (ISAP) ASSESSED BY CO-REGISTERED SPECT AND MRI, Neurology, 44(4), 1994, pp. 10000139-10000139